Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy

Annals of the New York Academy of Sciences

Volumn 1034, Issue , 2004, Pages 200-210

  Palagiano, Antonio ^a,e   Bulletti, C ^b   Pace, M C ^a   De Ziegler, D ^c   Cicinelli, E ^d   Izzo, A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIVERSITY OF BARI   (Italy)

^e NONE   (Italy)

Author keywords

Infertility; Medical treatment of infertility; Threatened abortion; Vaginal progesterone

Indexed keywords

PLACEBO; PROGESTERONE;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; EMBRYO; FEMALE; GEL; HUMAN; IMMINENT ABORTION; INFERTILITY THERAPY; LUTEAL INSUFFICIENCY; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPONTANEOUS ABORTION; ULTRASOUND; UTERUS CONTRACTILITY;

EID: 14944349371     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1335.022     Document Type: Conference Paper

References (31)

1. EVANS, J.H. & N.A. BEISCHER. 1970. The prognosis of threatened abortion. Med. J. Aust. 2: 165-168.
2. PECKHMAN, C.H. 1970. Uterine bleeding during pregnancy. Obstet. Gynecol. 35: 937-941.
3. WILLIAMS, M.A., R. MITTENDORF, E. LIEBERMAN et al. 1991. Adverse infant outcomes associated with first-trimester vaginal bleeding. Obstet. Gynecol. 78: 14-18.
4. SIPILA, P., A.L. HARTIKAINEN-SORRI, H. OJA et al. 1992. Perinatal outcome of pregnancies complicated by vaginal bleeding. Br. J. Obstet. Gynecol. 99: 959-963.
5. YIP, S.K., D. SAHOTA, L.P. CHEUNG et al. 2003. Accuracy of clinical diagnostic methods of threatened abortion. Gynecol. Obstet. Invest. 56: 38-42.
6. STERN, J.J., A.D. DORFMANN, A.J. GUTIERREZ-NAJAR et al. 1996. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil. Steril. 65: 250-253.
7. BULLETTI, C. & C. FLAMIGNI. 1993. Reproductive failure due to spontaneous abortion and recurrent miscarriage. Hum. Reprod. 7: 533-536.
8. BULLETTI, C., D. DE ZIEGLER, V. POLLI et al. 2000. Uterine contractility during the menstrual cycle. Hum. Reprod. 15: 81-89.
9. CHANTILIS, S.J., K.M. ZEITOUN, S.I. PATEL et al. 1999. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertil. Steril. 72: 823-829.
10. POULY, J.L., S. BASSIL, R. FRYDMAN et al. 1996. Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone. Hum. Reprod. 11: 2085-2089.
11. ABATE, A., M. PERINO, F.G. ABATE et al. 1999. Intramuscular versus vaginal administration of progesterone for luteal phase support after in vitro fertilization and embryo transfer: a comparative randomized study. Clin. Exp. Obstet. Gynecol. 26: 203-206.
12. SCHOOLCRAFT, W.B., J.S. HESLA & M.J. GEE. 2000. Experience with progesterone gel for luteal support in a highly successful IVF programme. Hum. Reprod. 15: 1284-1288.
13. GERHARD, I., B. GWINNER, W. EGGERT-KRUSE & B. RUNNEBAUM. 1987. Double-blind controlled trial of progesterone substitution in threatened abortion. Biol. Res. Pregnancy Perinatol. 8: 26-34.
14. BULLETTI, C., D. DE ZIEGLER, B. DE MOUSTIER et al. 1998. The first uterine pass of radioactive terbutaline in the human perfused uterus. Am. Soc. Reprod. Med. Abstract.
15. BULLETTI, C., D. DE ZIEGLER, C. FLAMIGNI et al. 1997. Targeted drug delivery in gynecology: the first uterine pass effect. Hum. Reprod. 12: 1073-1079.
16. MARCH OF DIMES. 2001. Health Library: Fact Sheets.
17. PLOUFFE, L., JR., E.W. WHITE, S.T. THO et al. 1992. Etiologic factors of recurrent abortions and subsequent reproductive performance of couples: have we made any progress in the past 10 years? Am. J. Obstet. Gynecol. 167: 313.
18. STRAY-PEDERSEN, B. & S. STRAY-PEDERSEN. 1984. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am. J. Obstet. Gynecol. 148: 140.
19. TULPPALA, M., T. PALOSUO, T. RAMSAY et al. 1993. Prospective study of 63 couples with a history of recurrent spontaneous abortion: contributing factors and outcome of subsequent pregnancies. Hum. Reprod. 8: 764.
20. HICKMAN, T.N., M. LE SHIH, H.A. ZACUR et al. 2002. Decreased progesterone receptor expression in the intermediate trophoblastic cells of spontaneous abortion. Fertil. Steril. 77: 1001-1005.
21. CHECK, J.H. 2002. Progesterone therapy versus follicle maturing drug-possible opposite effects on embryo implantation. Clin. Exp. Obstet. Gynecol. 29: 5-10
22. SPEROFF, L., R.H. GLASS & N. KASE, Eds. 1994. Clinical Gynecologic Endocrinology and Infertility-Part V: Infertility. Williams & Wilkins. Baltimore.
23. TANNIRANDORN, Y., S. SANGSAWANG, S. MANOTAYA et al. 2003. Fetal loss in threatened abortion after embryonic/fetal heart activity. J. Gynecol. Obstet. 81: 263-266.
24. NAGY, S., M. BUSH, J. STONE et al. 2003. Clinical significance of subchorionic and retroplacental hematomas detected in the first trimester of pregnancy. Obstet. Gynecol. 102: 94-100.
25. CICINELLI, E. & D. DE ZIEGLER. 1999. Transvaginal progesterone: evidence for a new functional "portal system" flowing from the vagina to the uterus. Hum. Reprod. Update 5: 365-372.
26. TOURGEMAN, D.E., C.C. SLATER, F.Z. STANCZYK & R.J. PAULSON. 2001. Endocrine and clinical effects of micronized estradiol administered vaginally or orally. Fertil. Steril. 75: 200-202.
27. 2 administration: effects on endometrial thickness, uterine perfusion, and contractility. Fertil. Steril. 76: 994-998.
28. NAVOT, D., N. LAUFER, J. KOPOLOVIC et al. 1986. Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N. Engl. J. Med. 314:806-811.
29. LOBO, R.A. 1992. The role of progestins in hormone replacement therapy. Am. J. Obstet. Gynecol. 166: 1997-2004.
30. BULLETTI, C., R.A. PREFETTO, G. BAZZOCCHI et al. 1993. Electromechanical activities of human uteri during extra-corporeal perfusion with ovarian steroids. Hum. Reprod. 8: 1558-1563.
31. CHOI, B.C., K. POLGAR, L. XIAO & J.A. HILL. 2000. Progesterone inhibits in vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum. Reprod. 15(suppl. 1): 46-59.